CCHFV vaccine development, current challenges, limitations, and future directions
Crimean-Congo hemorrhagic fever (CCHF) is the most prevalent tick-borne viral disease affecting humans. The disease is life-threatening in many regions of the developing world, including Africa, Asia, the Middle East, and Southern Europe. In line with the rapidly increasing disease prevalence, vario...
| Published in: | Frontiers in Immunology |
|---|---|
| Main Authors: | Büşra Ahata, Günseli Bayram Akçapınar |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-09-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1238882/full |
Similar Items
A mRNA Vaccine for Crimean–Congo Hemorrhagic Fever Virus Expressing Non-Fusion GnGc Using NSm Linker Elicits Unexpected Immune Responses in Mice
by: Tong Chen, et al.
Published: (2024-02-01)
by: Tong Chen, et al.
Published: (2024-02-01)
Induced protection from a CCHFV-M DNA vaccine requires CD8+ T cells
by: Joseph W. Golden, et al.
Published: (2023-09-01)
by: Joseph W. Golden, et al.
Published: (2023-09-01)
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
by: Aleksandra Anna Zasada, et al.
Published: (2023-08-01)
by: Aleksandra Anna Zasada, et al.
Published: (2023-08-01)
Development of a Novel Plasmid-based Eukaryotic Model to Investigate Crimean-Congo Hemorrhagic Fever Virus
by: Nesibe Selma GÜLER ÇETİN, et al.
Published: (2024-04-01)
by: Nesibe Selma GÜLER ÇETİN, et al.
Published: (2024-04-01)
Recent Advances in Crimean-Congo Hemorrhagic Fever Virus Detection, Treatment, and Vaccination: Overview of Current Status and Challenges
by: Khursheed Muzammil, et al.
Published: (2024-06-01)
by: Khursheed Muzammil, et al.
Published: (2024-06-01)
Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses
by: Tong Chen, et al.
Published: (2023-05-01)
by: Tong Chen, et al.
Published: (2023-05-01)
Crimean–Congo Hemorrhagic Fever Virus: Progress in Vaccine Development
by: Aykut Ozdarendeli
Published: (2023-08-01)
by: Aykut Ozdarendeli
Published: (2023-08-01)
Drivers of Crimean-Congo Hemorrhagic Fever in Natural Host and Effects of Control Measures, Bulgaria
by: Georgina Limon, et al.
Published: (2025-09-01)
by: Georgina Limon, et al.
Published: (2025-09-01)
RNA Phage VLP-Based Vaccine Platforms
by: David S. Peabody, et al.
Published: (2021-08-01)
by: David S. Peabody, et al.
Published: (2021-08-01)
Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
by: Qi Ma, et al.
Published: (2025-01-01)
by: Qi Ma, et al.
Published: (2025-01-01)
Crimean-Congo Hemorrhagic Fever Virus Africa 1 Lineage in Hyalomma dromedarii Ticks, Algeria, 2023
by: Marbouha Temani, et al.
Published: (2025-08-01)
by: Marbouha Temani, et al.
Published: (2025-08-01)
Crimean-Congo Hemorrhagic Fever Virus in Ticks Collected from Cattle, Corsica, France, 2023
by: Paloma Kiwan, et al.
Published: (2024-05-01)
by: Paloma Kiwan, et al.
Published: (2024-05-01)
Virus like particles as a platform for cancer vaccine development
by: Hui Kian Ong, et al.
Published: (2017-11-01)
by: Hui Kian Ong, et al.
Published: (2017-11-01)
A Virus-Like Particle-Based Vaccine Candidate against the Tick-Borne Powassan Virus Induces Neutralizing Antibodies in a Mouse Model
by: Velasco Cimica, et al.
Published: (2021-05-01)
by: Velasco Cimica, et al.
Published: (2021-05-01)
Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1
by: Yong-Liang Hu, et al.
Published: (2023-03-01)
by: Yong-Liang Hu, et al.
Published: (2023-03-01)
Crimean-Congo Hemorrhagic Fever Virus for Clinicians—Epidemiology, Clinical Manifestations, and Prevention
by: Maria G. Frank, et al.
Published: (2024-05-01)
by: Maria G. Frank, et al.
Published: (2024-05-01)
Crimean Congo Hemorrhagic Fever Virus for Clinicians—Virology, Pathogenesis, and Pathology
by: Maria G. Frank, et al.
Published: (2024-05-01)
by: Maria G. Frank, et al.
Published: (2024-05-01)
Unveiling the threat: Balochistan's path to congo virus endemicity
by: Rida Irfan, et al.
Published: (2024-04-01)
by: Rida Irfan, et al.
Published: (2024-04-01)
Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
by: Minna M. Hankaniemi, et al.
Published: (2020-08-01)
by: Minna M. Hankaniemi, et al.
Published: (2020-08-01)
The new wave of Congo virus in Pakistan: emerging threat
by: Isra Masood, et al.
Published: (2023-11-01)
by: Isra Masood, et al.
Published: (2023-11-01)
Crimean-Congo Hemorrhagic Fever Virus for Clinicians—Diagnosis, Clinical Management, and Therapeutics
by: Maria G. Frank, et al.
Published: (2024-05-01)
by: Maria G. Frank, et al.
Published: (2024-05-01)
Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview
by: Ruth Henríquez, et al.
Published: (2024-08-01)
by: Ruth Henríquez, et al.
Published: (2024-08-01)
Geographical Variability Affects CCHFV Detection by RT–PCR: A Tool for In-Silico Evaluation of Molecular Assays
by: Cesare E. M. Gruber, et al.
Published: (2019-10-01)
by: Cesare E. M. Gruber, et al.
Published: (2019-10-01)
An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean–Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a Target
by: Syed Zawar Shah, et al.
Published: (2022-12-01)
by: Syed Zawar Shah, et al.
Published: (2022-12-01)
Seroepidemiology of Crimean-Congo Hemorrhagic Fever Virus (CCHFV) in Cattle across Three Livestock Pastoral Regions in Kenya
by: Isabel Blanco-Penedo, et al.
Published: (2021-08-01)
by: Isabel Blanco-Penedo, et al.
Published: (2021-08-01)
Virus-like particle vaccines: immunology and formulation for clinical translation
by: Braeden Donaldson, et al.
Published: (2018-09-01)
by: Braeden Donaldson, et al.
Published: (2018-09-01)
Crimean-Congo Hemorrhagic Fever Outbreak in Refugee Settlement during COVID-19 Pandemic, Uganda, April 2021
by: Luke Nyakarahuka, et al.
Published: (2022-11-01)
by: Luke Nyakarahuka, et al.
Published: (2022-11-01)
In Vitro Assembly of Virus-Like Particles and Their Applications
by: Dinh To Le, et al.
Published: (2021-04-01)
by: Dinh To Le, et al.
Published: (2021-04-01)
Synthesis and characterization of human rotavirus A (<i>Reoviridae: Sedoreovirinae: Rotavirus: Rotavirus A</i>) virus-like particles
by: S. A. Cherepushkin, et al.
Published: (2021-03-01)
by: S. A. Cherepushkin, et al.
Published: (2021-03-01)
Crimean-Congo Hemorrhagic Fever Virus Kinetics in Serum, Saliva, and Urine, Iran, 2018
by: Malihe Metanat, et al.
Published: (2024-08-01)
by: Malihe Metanat, et al.
Published: (2024-08-01)
Immunization Against <i>Chlamydia trachomatis</i> Polymorphic Membrane Protein D Tetrapeptide Motifs Limits Early Female Reproductive Tract Infection in a Mouse Model
by: Amanda L. Collar, et al.
Published: (2025-02-01)
by: Amanda L. Collar, et al.
Published: (2025-02-01)
Fatal Case of Crimean-Congo Hemorrhagic Fever, Portugal, 2024
by: Líbia Zé-Zé, et al.
Published: (2025-01-01)
by: Líbia Zé-Zé, et al.
Published: (2025-01-01)
Prospectives of developing therapeutic HPV vaccines
by: Natalja M. Raevskaya, et al.
Published: (2024-10-01)
by: Natalja M. Raevskaya, et al.
Published: (2024-10-01)
Advances in Nucleic Acid Universal Influenza Vaccines
by: Liang Xu, et al.
Published: (2024-06-01)
by: Liang Xu, et al.
Published: (2024-06-01)
Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes
by: Yongping Yang, et al.
Published: (2023-08-01)
by: Yongping Yang, et al.
Published: (2023-08-01)
Crimean-Congo Hemorrhagic Fever Virus Seroprevalence in Human and Livestock Populations, Northern Tanzania
by: Ellen C. Hughes, et al.
Published: (2024-04-01)
by: Ellen C. Hughes, et al.
Published: (2024-04-01)
Seroprevalence and Risk Factors of Crimean–Congo Hemorrhagic Fever Exposure in Wild and Domestic Animals in Benin
by: Roland Eric Yessinou, et al.
Published: (2025-03-01)
by: Roland Eric Yessinou, et al.
Published: (2025-03-01)
Two Cases of Crimean-Congo Hemorrhagic Fever Detected in a Non-endemic Feast of Sacrifice
by: Ali Gümüş, et al.
Published: (2022-12-01)
by: Ali Gümüş, et al.
Published: (2022-12-01)
Biosensor-based methods for Crimean-Congo hemorrhagic fever virus detection
by: Milad Zandi, et al.
Published: (2021-01-01)
by: Milad Zandi, et al.
Published: (2021-01-01)
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
by: Vivek P. Chavda, et al.
Published: (2023-02-01)
by: Vivek P. Chavda, et al.
Published: (2023-02-01)
Similar Items
-
A mRNA Vaccine for Crimean–Congo Hemorrhagic Fever Virus Expressing Non-Fusion GnGc Using NSm Linker Elicits Unexpected Immune Responses in Mice
by: Tong Chen, et al.
Published: (2024-02-01) -
Induced protection from a CCHFV-M DNA vaccine requires CD8+ T cells
by: Joseph W. Golden, et al.
Published: (2023-09-01) -
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
by: Aleksandra Anna Zasada, et al.
Published: (2023-08-01) -
Development of a Novel Plasmid-based Eukaryotic Model to Investigate Crimean-Congo Hemorrhagic Fever Virus
by: Nesibe Selma GÜLER ÇETİN, et al.
Published: (2024-04-01) -
Recent Advances in Crimean-Congo Hemorrhagic Fever Virus Detection, Treatment, and Vaccination: Overview of Current Status and Challenges
by: Khursheed Muzammil, et al.
Published: (2024-06-01)
